SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-041592
Filing Date
2023-08-11
Accepted
2023-08-11 07:10:26
Documents
107
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K asln-20230630.htm   iXBRL 6-K 214199
2 EX-99.1 asln-ex99_1.htm EX-99.1 458974
3 EX-99.2 asln-ex99_2.htm   iXBRL EX-99.2 2563848
4 GRAPHIC img183322545_0.jpg GRAPHIC 12654
  Complete submission text file 0000950170-23-041592.txt   14643162

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asln-20230630_cal.xml EX-101.CAL 61358
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asln-20230630_lab.xml EX-101.LAB 750678
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asln-20230630.xsd EX-101.SCH 130309
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asln-20230630_def.xml EX-101.DEF 429873
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asln-20230630_pre.xml EX-101.PRE 616538
101 EXTRACTED XBRL INSTANCE DOCUMENT asln-20230630_htm.xml XML 3572846
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38475 | Film No.: 231161492
SIC: 2834 Pharmaceutical Preparations